|
Neurotransmitters are chemicals that are used to relay, amplify and modulate electrical signals between a neurons and another cell. According to the dogma of the 1960's, a chemical can be classified as a neurotransmitter if it respects the following conditions:
- It is synthesized endogenously; that is, within the presynaptic neuron
- It is available in sufficient quantity in the presynaptic neuron to exert an effect on the postsynaptic neuron
- Externally administered, it must mimic the endogenously released substance
- A biochemical mechanism for inactivation must be present
However, there are other materials such as the zinc ion, which are neither synthesized nor cataboloized and are considered neurotransmitters by some. Thus, the old definitions are being revised.
Types of neurotransmitters
Neurotransmitters can be broadly classified into small-molecule transmitters and neuroactive peptides. Around 10 small-molecule neurotransmitters are generally admitted: acetylcholine, 5 amines, and 3 or 4 amino acids (depending on exact definition used). Purines (Adenosine, ATP, GTP and their derivatives) are neurotransmitters. Fatty acids are also recieving attention as the potential endogenous cannabinoid (Anandamide etc.) Over 50 neuroactive peptides have been found, among them hormones such as LH or insulin that have specific local actions in addition to their long-range signalling properties. Single ions, such as synaptically-released zinc are also considered neurotransmitters by some.
It is important to appreciate that it is the receptor that dictates the neurotransmitter's effect.
Mechanism of action
Within the cells, small-molecule neurotransmitter molecules are usually packaged in vesicles. When an action potential travels to the synapse, the rapid depolarization causes calcium ion channels to open. Calcium then stimulates the transport of vesicles to the synaptic membrane: the vesicle and cell membrane fuse, leading to the release of the packaged neurotransmitter, a mechanism called exocytosis.
The neurotransmitters then diffuse across the synaptic cleft to bind to receptors. The receptors are broadly classified into ionotropic and metabotropic receptors. Ionotropic receptors are ligand-gated ion channels that open or close through neurotransmitter binding. Metabotropic receptor, which can have a diverse range of effects on a cell, transduct the signal by second messenger systems.
Neuroactive peptides are synthesized in the neuron's soma and are transported through the axon to the synapse. They are usually packaged into dense-core vesicles and are released through a similar, but metabolically distinct, form of exocytosis used for small-molecule synaptic vesicles.
Post-synaptic effect
A neurotransmitter's effect is determined by its receptor. For example, GABA can act on both rapid or slow inhibitory receptors (the GABA_A_receptor and GABA_B_receptor receptor respectively). However many other neurotransmitters can have excitatory or inhibitory actions depending on which receptor they bind to.
Neurotransmitters may cause either excitatory or inhibitory post-synaptic potentials. That is, they may help the initiation of a nerve impulse in the receiving neuron, or they may discourage such an impulse, by modifying the local membrane voltage potential. In the central nervous system, combined input from several synapses is usually required to trigger an action potential. Glutamate is the most prominent of excitatory transmitters; GABA and glycine are well-known inhibitory neurotransmitters.
Many neurotransmitters are removed from the synaptic cleft by a process is called reuptake (or often simply uptake). Without reuptake, the molecules might continue to stimulate or inhibit the firing of the postsynaptic neuron. Another mechanism for removal of a neurotransmitter is digestion by an enzyme. For example, at cholinergic synapses (where acetylcholine is the neurotransmitter) the enzyme acetylcholinesterase breaks down the acetylcholine. Neuroactive peptides are usually removed from the cleft by diffusion, and eventual break down by proteases.
Specific actions
While some neurotransmitters (glutamate, GABA, glycine) are used very generally throughout the central nervous system, others are only used in certain brain regions by particular classes of nerve cells. Serotonin is released specifically by cells in the brainstem, in an area called the raphe nuclei. Dopamine classically modulates two systems: the brain's reward mechanism, and movement control.
Neurotransmitters which have these types of specific actions are often targeted by drugs. Cocaine, for example, blocks the reuptake of dopamine, leaving these neurotransmitters in the synaptic gap longer. Prozac is a serotonin reuptake inhibitor, hence potentiating its effect. AMPT prevents the conversion of tyrosine to L-DOPA, the precursor to dopamine; reserpine prevents dopamine storage within vesicles; and deprenyl inhibits monoamine oxidase (MAO) B and thus increases dopamine levels.
Finally, soime neurotransmitter/neuromodulators like zinc can not only moduloate the sensitivity of a receptor to other neurotransmitters (allosteric modulation) but can even penetrate specific, gated channels in post synaptic neurons, thus entering the post synaptic cells. This "translocation" is another mechanism by which syanptic transmitters can affect posstsynaptic cells.
Diseases may affect specific neurotransmitter pathways. For example, Parkinson's disease is at least in part related to failure of dopaminergic cells in deep-brain nuclei, for example the substantia nigra. Treatments potentiating the effect of dopamine precursors have been proposed and effected, with moderate success.
Common neurotransmitters
See also
External links
| 
